General Information of Drug (ID: DM6PE9A)

Drug Name
NN9068
Indication
Disease Entry ICD 11 Status REF
Type-2 diabetes 5A11 Phase 3 [1]
Cross-matching ID
TTD ID
D0L6BH

References

1 Clinical pipeline report, company report or official report of Novo Nordisk A/S.